[DOI] [Google Scholar] 98.Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., et al
The safety profile of BPC-157 is not well-established due to a lack of clinical data on the compound
If it doesn't meet the stated purity, we replace it at no cost
How to Use the Wolverine Stack How people typically use BPC-157 + TB-500 in the Wolverine stack (again, mostly in unregulated/experimental settings): Administration : Injectable form is common (subcutaneous or intramuscular near the site of injury for BPC-157
Verhaeverbeke, 1997) One trial of predominantly vegetarian families from India (Deshmukh, 2010) One trial of half vegetarians and half vegans whose responses were mixed together (Del Bo, 2019) One trial of B12 supplementation in vegans who werent previously supplementing (Crane, 1998) The dotted lines represent the trial of only vegans (500 g per day by Crane et al.) and the trial of half vegetarians and half vegans (50 g and 2,000/wk by Del Bo, 2019)